![Stefan Sperl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Sperl
Verksamhetschef på
KIORA PHARMACEUTICALS, INC.
Profil
Stefan Sperl was the founder of Panoptes Pharma GmbH, founded in 2013, holding the title of Chief Operating Officer.
Dr. Sperl is currently the Executive Vice President-CMC & Operations at Kiora Pharmaceuticals, Inc. Formerly, Project Manager at Nabriva Therapeutics GmbH.
Education includes a doctorate from Max Planck Institute of Biochemistry.
Aktiva positioner av Stefan Sperl
| Företag | Position | Start |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Verksamhetschef | - |
Tidigare kända positioner av Stefan Sperl
| Företag | Position | Slut |
|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Företagsledare/Principal | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Grundare | - |
Stefan Sperls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
8
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Max Planck Institute of Biochemistry
 Max Planck Institute of Biochemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Health Technology |
